A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge

Previous studies have established that strain 68–1-derived Rhesus cytomegalovirus (RhCMV) vectors expressing simian immune deficiency virus (SIV) proteins (RhCMV/SIV) are able to elicit and maintain cellular immune responses that provide protection against mucosal challenge with highly pathogenic SI...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Transl Med
Päätekijät: Hansen, Scott G., Marshall, Emily E., Malouli, Daniel, Ventura, Abigail B., Hughes, Colette M., Ainslie, Emily, Ford, Julia C., Morrow, David, Gilbride, Roxanne M., Bae, Jin Y., Legasse, Alfred W., Oswald, Kelli, Shoemaker, Rebecca, Berkemeier, Brian, Bosche, William J., Hull, Michael, Womack, Jennie, Shao, Jason, Edlefsen, Paul T., Reed, Jason S., Burwitz, Ben J., Sacha, Jonah B., Axthelm, Michael K., Früh, Klaus, Lifson, Jeffrey D., Picker, Louis J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788755/
https://ncbi.nlm.nih.gov/pubmed/31316007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aaw2607
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia